Influence of resection margins and treatment on survival in patients with pancreatic cancer: meta-analysis of randomized controlled trials.
暂无分享,去创建一个
T. Takada | M. Büchler | J. Neoptolemos | D. Stocken | C. Bassi | M. Wente | G. Butturini | C. Dervenis | K. Bakkevold | H. Jeekel | J. Klinkenbijl | H. Amano
[1] W. Scheithauer,et al. Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] P. Murawa,et al. Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group , 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] B. Chauffert,et al. Phase III trial comparing initial chemoradiotherapy (intermittent cisplatin and infusional 5-FU) followed by gemcitabine vs. gemcitabine alone in patients with locally advanced non metastatic pancreatic cancer: A FFCD-SFRO study. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] T. Takada,et al. Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer , 2004, British Journal of Cancer.
[5] H. Friess,et al. Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma , 2004, The British journal of surgery.
[6] Helen Hickey,et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. , 2004, The New England journal of medicine.
[7] T. Takada,et al. Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? , 2002, Cancer.
[8] I Ihse,et al. Influence of Resection Margins on Survival for Patients With Pancreatic Cancer Treated by Adjuvant Chemoradiation and/or Chemotherapy in the ESPAC-1 Randomized Controlled Trial , 2001, Annals of surgery.
[9] D. Kerr,et al. Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial , 2001, The Lancet.
[10] J. Forgensen. Resected adenocarcinoma of the pancreas--616 patients: results, outcomes, and prognostic indicators. , 2001, Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract.
[11] F. Bray,et al. Cancer burden in the year 2000. The global picture. , 2001, European journal of cancer.
[12] K. Lillemoe,et al. Resected adenocarcinoma of the pancreas— 616 patients: Results, outcomes, and prognostic indicators , 2000, Journal of Gastrointestinal Surgery.
[13] J. Jeekel,et al. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group. , 1999, Annals of surgery.
[14] D. Winchester,et al. Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database. , 1999, Journal of the American College of Surgeons.
[15] D. Deziel,et al. Prognostic Factors Associated with Resectable Adenocarcinoma of the Head of the Pancreas , 1999, The American surgeon.
[16] J. Neoptolemos,et al. Treatment and survival in 13560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: An epidemiological study , 1995, The British journal of surgery.
[17] T. Colby,et al. Long‐Term Survival After Resection for Ductal Adenocarcinoma of the Pancreas Is It Really Improving? , 1995, Annals of surgery.
[18] S. Ellenberg,et al. Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection. , 1985, Archives of surgery.
[19] M. Pike,et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. , 1977, British Journal of Cancer.
[20] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[21] T. Eberlein. Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic Cancer: A Randomized Controlled Trial , 2008 .
[22] A. Jemal,et al. Cancer Statistics, 2005 , 2005, CA: a cancer journal for clinicians.
[23] O. Dahl,et al. Adjuvant combination chemotherapy (AMF) following radical resection of carcinoma of the pancreas and papilla of Vater--results of a controlled, prospective, randomised multicentre study. , 1993, European journal of cancer.
[24] L. Way,et al. Prognostic indicators for survival after resection of pancreatic adenocarcinoma. , 1993, American journal of surgery.
[25] U. G. Dailey. Cancer,Facts and Figures about. , 2022, Journal of the National Medical Association.